Table 3. Prevalence of common diagnosed chronic conditions among patients at GP encounters across three studies.
| Knox et al. estimates (2005, n = 9,156) | Harrison et al. (2008–09, n = 8,707) | Current estimates (2012–16, n = 43,501) | |
|---|---|---|---|
| Circulatory | 30.0% (28.1–31.7) | 31.3% (29.4–33.1) | 32.4% (31.5–33.4) |
| Hypertension | 23.3% (21.8–24.9) | 26.6% (24.9–33.1) | 26.5% (25.6–27.3) |
| Ischaemic Heart Disease | 9.5% (8.5–10.5) | 8.7% (7.7–9.8) | 7.8% (7.4–8.2) |
| Cerebrovascular Accident | 3.7% (3.0–4.5) | 2.9% (2.3–3.5) | 2.6% (2.4–2.8) |
| Congestive Heart Failure | 3.2% (2.7–3.7) | 2.9% (2.4–3.4) | 2.6% (2.4–2.8) |
| Peripheral Vascular Disease | 2.0% (1.5–2.5) | N/A | 1.8% (1.7–2.0) |
| Musculoskeletal system and connective tissue | N/A | 26.4 (24.6–28.2) | 32.1% (31.1–33.0) |
| Any Arthritis | 22.8% (21.1–24.5) | 19.7% (18.1–21.4) | 25.0% (24.1–25.9) |
| Rheumatoid | 1.0% (0.8–1.2) | 1.0% (0.7–1.2) | 1.3% (1.2–1.5) |
| Osteoarthritis | 20.0% (18.3–21.6) | 17.8% (16.2–19.4) | 22.7% (21.8–23.6) |
| Other and unknown | N/A | 2.0% (1.7–2.4) | 2.0% (1.9–2.2) |
| Chronic Back Pain | 10.1% (9.0–11.1) | 6.4% (5.5–7.2) | 9.7% (9.2–10.2) |
| Osteoporosis | N/A | 4.8% (4.2–5.5) | 5.8% (5.4–6.1) |
| Endocrine, nutritional and metabolic diseases | N/A | 30.8% (29.0–32.6) | 30.7% (29.9–31.6) |
| Hyperlipidaemia | 15.9% (14.7–17.2) | 18.5% (17.0–20.0) | 16.6% (15.9–17.3) |
| Diabetes all | 8.3% (7.5–9.0) | 9.2% (8.3–10.1) | 10.4% (10.0–10.8) |
| Type 1 | 0.6% (0.4–0.8) | 0.9% (0.6–1.2) | 0.9% (0.8–1.0) |
| Type 2 | 7.2% (6.5–7.9) | 8.3% (7.5–9.1) | 9.6% (9.2–10.0) |
| Psychological Problems | 24.8% (23.2–26.3) | 22.1% (20.6–23.7) | 26.7% (25.9–27.5) |
| Depression | 14.2% (13.0–15.4) | 13.7% (12.6–14.7) | 16.3% (15.8–16.9) |
| Anxiety | 10.7% (9.6–11.8) | 8.3% (7.3–9.4) | 11.9% (11.4–12.4) |
| Insomnia | 5.5% (4.6–6.4) | N/A | 3.7% (3.4–4.0) |
| Digestive | N/A | 14.6% (13.4–15.8) | 15.1% (14.5–15.7) |
| GORD | 13.1% (11.9–14.4) | 11.6% (10.5–12.6) | 11.3% (10.7–11.8) |
| Respiratory Disease | N/A | 13.7% (12.6–14.7) | 14.6% (14.1–15.1) |
| Asthma | 10.7% (9.8–11.6) | 9.5% (8.7–10.3) | 8.3% (8.0–8.7) |
| COAD/COPD | 3.6% (3.1–4.2) | 4.1% (3.4–4.7) | 4.5% (4.2–4.7) |
| Malignant Neoplasms | 3.1% (2.6–3.6) | 5.0% (4.4–5.7) | 6.2% (5.9–6.5) |
Note: GORD = gastro oesophageal reflux disease, COAD/COPD chronic obstructive airways disease/chronic obstructive pulmonary disease
N/A: Result not available due to chronic condition not being measured